Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta
about
Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's diseasePeroxisome Proliferator-Activated Receptor γ Is a Target for Halogenated Analogs of Bisphenol ADevelopment of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicalsThe phytoestrogen genistein affects zebrafish development through two different pathwaysPathways to tamoxifen resistance.Rapid changes in cardiac myofilament function following the acute activation of estrogen receptor-alpha.New stably transfected bioluminescent cells expressing FLAG epitope-tagged estrogen receptors to study their chromatin recruitment.Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin.The potential health effects of dietary phytoestrogensEstrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediatedCombined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms.Two panels of steroid receptor luciferase reporter cell lines for compound profiling.Effects of selective and combined activation of estrogen receptor α and β on reproductive organ development and sexual behaviour in Japanese quail (Coturnix japonica).Bacterial biosensors for evaluating potential impacts of estrogenic endocrine disrupting compounds in multiple species.Evidence of ERalpha and ERbeta selectivity and partial estrogen agonism in traditional Chinese medicine.2,3-cis-2R,3R-(-)-epiafzelechin-3-O-p-coumarate, a novel flavan-3-ol isolated from Fallopia convolvulus seed, is an estrogen receptor agonist in human cell lines.Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities.Estrogen receptor β ligands: recent advances and biomedical applications.Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action.Renoprotective effects of a selective estrogen receptor modulator, raloxifene, in an animal model of diabetic nephropathyGeneration of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.Reporter Cell Lines for the Characterization of the Interactions between Human Nuclear Receptors and Endocrine Disruptors.Reporter cell lines to evaluate the selectivity of chemicals for human and zebrafish estrogen and peroxysome proliferator activated γ receptorsNutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.Molecular and Biochemical Analysis of the Estrogenic and Proliferative Properties of Vitamin E Compounds.Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.Derailed estrogen signaling and breast cancer: an authentic couple.The preventive effect of biochanin a on bone loss in ovariectomized rats: involvement in regulation of growth and activity of osteoblasts and osteoclasts.Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cellsMultiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.Biochanin a promotes osteogenic but inhibits adipogenic differentiation: evidence with primary adipose-derived stem cellsIn vitro cytochrome p450 formation of a mono-hydroxylated metabolite of zearalenone exhibiting estrogenic activities: possible occurrence of this metabolite in vivo.Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.The influence of the membrane on neurosteroid actions at GABA(A) receptors.Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive mannerMechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks.Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease.Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species.Chemical and toxicological assessment of a full-scale biosolid compost.
P2860
Q26998487-7C8D7CF6-50D4-46FD-9C80-785AEDCBBF3FQ27667794-D8FCBD05-9BD1-49A6-AF2C-835220079451Q28388405-E02C8F6F-47F4-440E-8DE4-939405231D9EQ28475074-AF29323E-DB27-4307-9BE4-42E63871A2DCQ30441001-49F711EA-4B82-4793-8C6A-A4B4231FD07FQ31079547-5E70D5D7-366D-4E5D-B172-664338929F7BQ33500874-CC03F9BE-F2B3-4FA5-B2C7-269DDD26BF17Q33633056-D54BE474-7E95-4B60-815F-D5D86433F9AEQ33643360-A58AF44C-1C8C-4783-8AEB-D2E14B90298AQ33676455-568D939F-B24D-41FA-B7A4-DE82C3D7D411Q33733756-A81A5226-C80A-4F50-991E-20FF802DC28FQ33772887-61E565AE-58D2-4000-832E-88B562E4070DQ33837335-501D5C46-A22A-4863-AC91-A05B75E34440Q33865918-98ADEDEB-1D91-4B87-9AF4-CFB9F6439A6AQ33890342-6CA611AA-3EEB-4ACF-A7C0-CBA8FE802837Q34363082-CE24B7B8-7039-4F97-9A8F-A30AE0B7CE13Q34773658-833753BD-9650-4675-A2B1-65872A3115FBQ34788711-C8C2FEF0-3130-4780-BBA7-B0C761DC95B8Q35016384-0F462D76-7EDD-436D-8379-5889A033C53BQ35057858-A6F9D49F-CD0C-4D3B-9446-9CCD84A6036DQ35230897-898ADAA3-297A-4F76-82E5-E959E1720827Q35534361-CFE17BFB-68CB-4E20-B5DD-49B9816C9DDCQ35591361-42626206-36CB-418B-B330-D82A831BC158Q35698866-5AF223EC-E769-4CDD-8D0A-F2A6D28A030DQ36267925-F58C6FA1-E416-4B7C-B5DB-4E6B797895C9Q36427475-8A9BBF7C-91F1-481C-9A58-7277993B911EQ36574234-FD733FD5-1047-4EA7-A8EF-6B4A6077339FQ36589361-9E58725A-0FF2-4993-A970-6E7806514A84Q36676676-DD6C3061-070F-47F0-9B48-CF0E27466DF7Q36857530-1ECEE59B-C3BF-4928-8EC8-EB464B0B36D2Q36946741-685D5C04-F3FF-4FE0-890F-47B8BC62A135Q36969596-ADAD38AA-B4A3-49B0-AE96-829B6BEF8AA6Q37188272-EA74E1F3-9FFE-413A-BBDD-31EC9F7EBC1CQ37294585-213C8D2C-7D92-4824-A0A7-B86EE479BE1FQ37525549-ACFC0AC3-38DB-43F2-AF06-8612A6C2A114Q37595210-F791FAB7-21B3-43C0-B990-90A51138815FQ38061846-3773B7FA-064F-4CF8-8B88-84083FB9786BQ38814359-A64FD06B-5411-4FE4-BF4D-0763D1C8AC1AQ39096632-C423CF3E-BB84-437A-9D0F-1B8F58FA9C32Q39285395-326E8C59-1D01-4392-8C55-222EF6B91D06
P2860
Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@ast
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@en
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@nl
type
label
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@ast
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@en
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@nl
prefLabel
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@ast
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@en
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@nl
P2093
P1476
Evaluation of ligand selectivi ...... strogen receptor alpha or beta
@en
P2093
Arnaud Pillon
Aurélie Escande
Fernando Larrea
Jean-Claude Nicolas
Jean-Pierre Cravedi
Nadège Servant
Patrick Balaguer
Peter Muhn
P304
P356
10.1016/J.BCP.2006.02.002
P407
P50
P577
2006-03-22T00:00:00Z